Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

ATP6 Activators

ATP6, also known as ATP synthase subunit a or ATPase subunit 6, is an integral membrane protein that forms a part of the F0 sector of mitochondrial ATP synthase, the enzyme complex responsible for ATP production during oxidative phosphorylation. This protein is encoded by the MT-ATP6 gene, which is located within the mitochondrial DNA, distinguishing it from most other human genes that are nuclear-encoded.ATP synthase is a crucial enzyme that synthesizes ATP from ADP and inorganic phosphate (Pi), the process driven by a proton gradient across the mitochondrial inner membrane. The F0 sector, where ATP6 is situated, functions as the proton channel and is essential for the translocation of protons from the intermembrane space back into the mitochondrial matrix. The energy released from this proton movement is harnessed by the F1 sector of the ATP synthase complex to catalyze the phosphorylation of ADP to ATP.

The ATP6 subunit is pivotal for forming the proton channel and ensuring the proper functioning of the enzyme. It interacts with other subunits of the F0 sector to facilitate the translocation of protons through the membrane. This process is tightly regulated and highly efficient, being fundamental for energy production in eukaryotic cells. Mutations in the MT-ATP6 gene can lead to mitochondrial disorders, such as Leigh syndrome and neuropathy, ataxia, and retinitis pigmentosa (NARP), which are characterized by a wide spectrum of manifestations, including neurodegenerative changes and muscle weakness. These conditions arise from a deficiency in ATP production due to impaired function of the ATP synthase complex.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Bafilomycin A1 is a known inhibitor of V-ATPase. Its temporary inhibition leads to a compensatory increase in ATP6V1A activity to restore proton gradient upon removal.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$66.00
$167.00
$673.00
$2601.00
109
(2)

Concanamycin A, similar to Bafilomycin A1, inhibits V-ATPase. It results in increased expression of ATP6V1A to compensate for the disrupted proton gradient when inhibition ceases.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Monensin is a carboxylic ionophore that alters intracellular pH. Cells may upregulate ATP6V1A to counteract the pH changes induced by Monensin.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine raises lysosomal pH, which may trigger a feedback response increasing ATP6V1A activity to reacidify the lysosome.

FCM Lysing solution (1x)

sc-3621
150 ml
$62.00
8
(1)

Ammonium chloride can alkalinize intracellular compartments, potentially inducing the activity of ATP6V1A to compensate and reacidify these environments.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Zinc has been shown to modulate ion channels and transporters activity, and may indirectly enhance ATP6V1A activity as part of cellular homeostasis mechanisms.

Copper(II) sulfate

7758-98-7sc-211133
sc-211133A
sc-211133B
100 g
500 g
1 kg
$46.00
$122.00
$189.00
3
(1)

Copper sulfate can interfere with cellular metal ion balance, potentially prompting an increase in ATP6V1A activity to maintain pH homeostasis.

Valinomycin

2001-95-8sc-200991
25 mg
$250.00
3
(1)

Valinomycin is a potassium ionophore that disrupts membrane potential, potentially inducing ATP6V1A activity to restore ionic balance.

FCCP

370-86-5sc-203578
sc-203578A
10 mg
50 mg
$94.00
$355.00
46
(1)

FCCP uncouples oxidative phosphorylation, which could lead to compensatory mechanisms including the upregulation of ATP6V1A to manage cellular energetics.